NYSE:MOHHealthcare
Reassessing Molina Healthcare (MOH) Valuation as Legal Probe Puts 2025 Guidance and Cost Assumptions in Focus
Grabar Law Office has launched an investigation into Molina Healthcare (MOH), questioning whether management adequately disclosed rising medical cost trends and a mismatch between premiums and underlying costs, which has put the company’s 2025 financial guidance under sharper investor scrutiny.
See our latest analysis for Molina Healthcare.
The investigation is landing after a volatile stretch, with Molina’s share price at $163.68 following a strong 1 month share price return, but a steep...